RecruitingNCT06725719
Translocator Protein PET/CT in Various TSPO-Related Disease
Sponsor
Tianjin Medical University
Enrollment
200 participants
Start Date
Nov 1, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
To evaluate the potential usefulness of 18F-DPA714/FDPA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various TSPO-related disease patients.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria1
- \- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled TSPO PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
Exclusion Criteria1
- \- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TEST18F-DPA714/FDPA
Each subject receive a single intravenous injection of 18F-DPA714/FDPA, and undergo PET/CT or MRI imaging within the specificed time.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06725719
Related Trials
The Beneficial Effects of Naps on Motor Learning
NCT043121261 location
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
NCT066159731 location
Tracking a Tactile Signal Along the Nervous System
NCT062318101 location
fNIRS for Monitoring Cortical Activity in Stroke Recovery
NCT076235121 location
Virtual Reality Mirror Therapy With Focused Object-Directed Attention System
NCT075257131 location